| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +1,200 | 3.1% | $222.55 | +$267,060 |
| Sells | 3 | -37,990 | 97% | $217.30 | -$8,255,322 |
| Net | -2 | -36,790 | -94% | -$7,988,262 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Scott D. Farmer | Executive Chairman, Director, 10%+ Owner | $10,542,972,495 | 28 Jan 2026 | ||
| Todd M. Schneider | CEO and Director, Director | $150,532,006 | -$3,821,791 | -2.5% | 11 Aug 2025 |
| Robert E. Coletti | Director | $69,808,490 | 13 Mar 2026 | ||
| Jim Rozakis | Exec. Vice President & COO | $62,137,059 | -$380,740 | -0.61% | 11 Aug 2025 |
| Thomas E. Frooman | Sr VP, Secretary & Gen Counsel | $57,887,735 | 29 Jul 2021 | ||
| J. Michael Hansen | Vp & Cfo | $42,034,885 | 12 Aug 2024 | ||
| Michael L. Thompson | Executive Vice President & CAO | $32,097,045 | 10 Aug 2023 | ||
| Gerald S. Adolph | Director | $24,083,425 | 24 Jul 2024 | ||
| Scott Garula | Vp & Cfo | $21,945,900 | 11 Aug 2025 | ||
| John F. Barrett | Director | $16,686,985 | 14 May 2024 | ||
| Ronald W. Tysoe | Director | $11,891,159 | -$4,052,791 | -25% | 13 Mar 2026 |
| Joseph Scaminace | Director | $8,948,514 | 29 Oct 2025 | ||
| Karen L. Carnahan | Director | $6,440,763 | 13 Mar 2026 | ||
| Melanie W. Barstad | Director | $6,307,479 | 13 Mar 2026 | ||
| David Brock Denton | Sr VP, Secretary & Gen Counsel | $5,953,892 | 11 Aug 2025 | ||
| Martin Mucci | Director | $641,232 | +$267,060 | +71% | 29 Oct 2025 |
| Beverly K. Carmichael | Director | $275,048 | 29 Oct 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Ronald W. Tysoe | CTAS | Phantom Stock Units | Award | 0.23% | 89.52 | 38,739 | 13 Mar 2026 | Direct | ||
| Melanie W. Barstad | CTAS | Phantom Stock Units | Award | 0.23% | 10.15 | 4,393 | 13 Mar 2026 | Direct | ||
| Karen L. Carnahan | CTAS | Phantom Stock Units | Award | 0.23% | 15.02 | 6,502 | 13 Mar 2026 | Direct | ||
| Robert E. Coletti | CTAS | Phantom Stock Units | Award | 0.23% | 25.59 | 11,076 | 13 Mar 2026 | Direct | ||
| Robert E. Coletti | CTAS | Common Stock | Gift | -26.8% | -5,200 | 14,200 | 28 Jan 2026 | Direct | ||
| Scott D. Farmer | CTAS | Common Stock | Gift | -1.75% | -10,400 | 584,992 | 28 Jan 2026 | Direct | ||
| Karen L. Carnahan | CTAS | Phantom Stock Units | Award | 2.34% | 148 | 6,487 | 20 Jan 2026 | Direct | ||
| Melanie W. Barstad | CTAS | Phantom Stock Units | Award | 3.9% | 165 | 4,383 | 20 Jan 2026 | Direct | ||
| Robert E. Coletti | CTAS | Phantom Stock Units | Award | 1.18% | 129 | 11,050 | 20 Jan 2026 | Direct | ||
| Robert E. Coletti | CTAS | Common Stock | Gift | -41.9% | -14,000 | 19,400 | 23 Dec 2025 | Direct | ||
| Robert E. Coletti | CTAS | Common Stock | Other | -61.2% | -545,732 | 345,600 | 23 Dec 2025 | By Trusts | ||
| Scott D. Farmer | CTAS | Common Stock | Gift | -4.64% | -29,000 | 595,392 | 23 Dec 2025 | Direct | ||
| Scott D. Farmer | CTAS | Common Stock | Other | -62.2% | -1,564,766 | 953,100 | 23 Dec 2025 | By Trusts | ||
| Ronald W. Tysoe | CTAS | Phantom Stock Units | Award | 0.24% | 92.07 | 38,649 | 15 Dec 2025 | Direct | ||
| Robert E. Coletti | CTAS | Phantom Stock Units | Award | 0.24% | 26.02 | 10,921 | 15 Dec 2025 | Direct | ||
| Karen L. Carnahan | CTAS | Phantom Stock Units | Award | 0.24% | 15.1 | 6,338 | 15 Dec 2025 | Direct | ||
| Melanie W. Barstad | CTAS | Phantom Stock Units | Award | 0.24% | 10.05 | 4,219 | 15 Dec 2025 | Direct | ||
| Ronald W. Tysoe | CTAS | Common Stock | Award | 2.29% | 503 | 22,448 | 29 Oct 2025 | Direct | ||
| Ronald W. Tysoe | CTAS | Common Stock Option (Right to Buy) | Award | 1,694 | 1,694 | 29 Oct 2025 | Direct | |||
| Martin Mucci | CTAS | Common Stock | Award | 19.2% | 503 | 3,124 | 29 Oct 2025 | Direct | ||
| Martin Mucci | CTAS | Stock Option (Right to Buy) | Award | 1,694 | 1,694 | 29 Oct 2025 | Direct | |||
| Joseph Scaminace | CTAS | Common Stock | Award | 1.17% | 503 | 43,596 | 29 Oct 2025 | Direct | ||
| Joseph Scaminace | CTAS | Stock Option (Right to Buy) | Award | 1,694 | 1,694 | 29 Oct 2025 | Direct | |||
| Robert E. Coletti | CTAS | Common Stock | Award | 3.67% | 503 | 14,200 | 29 Oct 2025 | Direct | ||
| Robert E. Coletti | CTAS | Stock Option (Right to Buy) | Award | 1,694 | 1,694 | 29 Oct 2025 | Direct | |||
| Karen L. Carnahan | CTAS | Common Stock | Award | 2.03% | 503 | 25,256 | 29 Oct 2025 | Direct | ||
| Karen L. Carnahan | CTAS | Stock Option (Right to Buy) | Award | 1,694 | 1,694 | 29 Oct 2025 | Direct | |||
| Beverly K. Carmichael | CTAS | Common Stock | Award | 60.1% | 503 | 1,340 | 29 Oct 2025 | Direct | ||
| Beverly K. Carmichael | CTAS | Stock Option (Right to Buy) | Award | 1,694 | 1,694 | 29 Oct 2025 | Direct | |||
| Melanie W. Barstad | CTAS | Common Stock | Award | 1.93% | 503 | 26,592 | 29 Oct 2025 | Direct | ||
| Melanie W. Barstad | CTAS | Stock Option (Right to Buy) | Award | 1,694 | 1,694 | 29 Oct 2025 | Direct | |||
| Robert E. Coletti | CTAS | Phantom Stock Units | Award | 1.22% | 132 | 10,895 | 28 Oct 2025 | Direct | ||
| Karen L. Carnahan | CTAS | Phantom Stock Units | Award | 2.45% | 151 | 6,323 | 28 Oct 2025 | Direct | ||
| Melanie W. Barstad | CTAS | Phantom Stock Units | Award | 4.15% | 168 | 4,209 | 28 Oct 2025 | Direct | ||
| Ronald W. Tysoe | CTAS | Phantom Stock Units | Award | 0.21% | 79.96 | 38,557 | 15 Aug 2025 | Direct | ||
| Robert E. Coletti | CTAS | Phantom Stock Units | Award | 0.21% | 22.32 | 10,764 | 15 Aug 2025 | Direct | ||
| Karen L. Carnahan | CTAS | Phantom Stock Units | Award | 0.21% | 12.8 | 6,172 | 15 Aug 2025 | Direct | ||
| Melanie W. Barstad | CTAS | Phantom Stock Units | Award | 0.21% | 8.38 | 4,041 | 15 Aug 2025 | Direct | ||
| David Brock Denton | CTAS | Common Stock | Award | 21.5% | 4,569 | 25,857 | 11 Aug 2025 | Direct | ||
| David Brock Denton | CTAS | Stock Option (Right to Buy) | Award | 15,552 | 15,552 | 11 Aug 2025 | Direct | |||
| Scott D. Farmer | CTAS | Common Stock | Award | 0.05% | 976 | 1,847,582 | 11 Aug 2025 | Direct | ||
| Jim Rozakis | CTAS | Common Stock | Tax liability | -10.3% | -30,384 | 264,876 | 11 Aug 2025 | Direct | ||
| Jim Rozakis | CTAS | Common Stock | Options Exercise | 19.6% | 45,976 | 280,271 | 11 Aug 2025 | Direct | ||
| Jim Rozakis | CTAS | Common Stock | Award | 2.71% | 6,852 | 259,521 | 11 Aug 2025 | Direct | ||
| Jim Rozakis | CTAS | Stock Option (Right to Buy) | Options Exercise | -100% | -45,976 | 0 | 11 Aug 2025 | Direct | ||
| Jim Rozakis | CTAS | Stock Option (Right to Buy) | Award | 23,326 | 23,326 | 11 Aug 2025 | Direct | |||
| Todd M. Schneider | CTAS | Common Stock | Award | 7.44% | 46,350 | 669,062 | 11 Aug 2025 | Direct | ||
| Scott Garula | CTAS | Common Stock | Award | 4.75% | 4,448 | 98,007 | 11 Aug 2025 | Direct | ||
| Scott Garula | CTAS | Stock Option (Right to Buy) | Award | 17,755 | 17,755 | 11 Aug 2025 | Direct | |||
| Ronald W. Tysoe | CTAS | Common Stock | Sale | -18.8% | $1,136,121 | $223.47 | -5,084 | 21,945 | 30 Jul 2025 | Direct |